JAHA:Journal of the American Heart Association This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Impact of Sex and Contact-to-Device Time on Clinical Outcomes in Acute ST-Segment Elevation Myocardial Infarction—Findings From the National Cardiovascular Data Registry [Health Services and Outcomes Research]
BackgroundEmergent myocardial reperfusion via primary percutaneous coronary intervention is optimal care for patients presenting with ST‐segment elevation myocardial infarction (STEMI). Delays in such interventions are associated with increases in mortality. With the shift in focus to contact‐to‐device (C2D) time as a new perfusion metric, this study was designed to examine how sex affects C2D time and mortality in STEMI patients.Methods and ResultsClinical data on male and female STEMI patients were extracted and analyzed from the National Cardiovascular Data Registry from July 1, 2008 to December 31, 2014. A total ...
Source: JAHA:Journal of the American Heart Association - January 11, 2017 Category: Cardiology Authors: Roswell, R. O., Kunkes, J., Chen, A. Y., Chiswell, K., Iqbal, S., Roe, M. T., Bangalore, S. Tags: Health Services, Mortality/Survival, Quality and Outcomes, Statements and Guidelines Original Research Source Type: research

Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial [Coronary Heart Disease]
We examined predictors of nonuse of high‐potency statins after acute coronary syndromes.Methods and ResultsThe Stabilization of pLaques usIng Darapladib‐Thrombolysis in Myocardial Infarction (SOLID‐TIMI 52) trial enrolled patients after an acute coronary syndrome in 36 countries between 2009 and 2011. Statin use was strongly encouraged throughout the trial, and statin potency was at the discretion of the treating physician. A high‐potency statin was defined as ≥40 mg atorvastatin, ≥20 mg rosuvastatin, or 80 mg simvastatin daily. Predictors of nonuse of high‐potency statins were examined using logistic regr...
Source: JAHA:Journal of the American Heart Association - January 11, 2017 Category: Cardiology Authors: Eisen, A., Cannon, C. P., Braunwald, E., Steen, D. L., Zhou, J., Goodrich, E. L., Im, K., Dalby, A. J., Spinar, J., Daga, S., Lukas, M. A., O'Donoghue, M. L. Tags: Lipids and Cholesterol, Cardiovascular Disease, Risk Factors, Secondary Prevention, Acute Coronary Syndromes Original Research Source Type: research

Neurological Inȷury in Intermediate-Risk Transcatheter Aortic Valve Implantation [Corrections]
(Source: JAHA:Journal of the American Heart Association)
Source: JAHA:Journal of the American Heart Association - January 11, 2017 Category: Cardiology Tags: Correction Source Type: research

Bimodal Pattern of Coronary Microvascular Involvement in Diabetes Mellitus [Corrections]
(Source: JAHA:Journal of the American Heart Association)
Source: JAHA:Journal of the American Heart Association - January 11, 2017 Category: Cardiology Tags: Correction Source Type: research

Impact of Beta-Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population-Based Cohort Study [Epidemiology]
ConclusionsThe use of cardioprotective beta‐blockers for>30 days before surgery was associated with reduced mortality risk, whereas short‐term use of beta‐blockers was not associated with differences in mortality in patients with diabetes mellitus. (Source: JAHA:Journal of the American Heart Association)
Source: JAHA:Journal of the American Heart Association - January 10, 2017 Category: Cardiology Authors: Chen, R.-J., Chu, H., Tsai, L.-W. Tags: Diabetes, Type 2, Epidemiology Original Research Source Type: research